Search
for
Sort by
Research 361–390 of 1000+
- AUSTRALIAN TRIAL OF TOPICAL MINOXIDIL AND PLACEBO IN EARLY MALE PATTERN BALDNESS
- Exacerbation of alopecia areata: A possible complication of sodium tetradecyl sulphate foam sclerotherapy treatment for varicose veins
- Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
- Abstracts Pt.30
- A case of rapid progression of central centrifugal cicatricial alopecia after COVID-19 infection
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- Clinical study on the efficacy and tolerability of a topical regenerative treatment in patients with telogen effluvium and mild androgenetic alopecia
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Review of Baricitinib in the Treatment of Alopecia Areata.
- Spiritual Well-Being and Quality of Life Among Newly Diagnosed Palestinian Women with Breast Cancer: A Prospective Study
- AVALIAÇÃO DO TRATAMENTO COM MICROINFUSÃO DE MEDICAMENTOS EM PACIENTES COM ALOPECIA ANDROGENÉTICA ATENDIDOS NO AMBULATÓRIO DE TRICOLOGIA DA UFPA
- Dietary Habits in Japanese Patients with Alopecia Areata
- A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity
- Dietary Habits in Japanese Patients with Alopecia Areata
- Abstract P5-11-11: A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA)
- Quality of life assessment in patients with alopecia areata and androgenetic alopecia in the People’s Republic of China
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Androgenetic Alopecia: Pathogenesis, Evaluation, and Management
- Pharmacotherapy of alopecia areata
- A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Effectiveness of Botanically Derived Inhibitors of 5-<i>α</i>-Reductase in the Treatment of Androgenetic Alopecia
- Tralokinumab Treatment in Adult Atopic Dermatitis Patients: 28‐Week Evaluation of Clinical Effectiveness, Safety, Serum Proteins and Total IgE Levels
- Folliculitis decalvans managed with adalimumab: A case report
- The psychosocial consequences of androgenetic alopecia: a review of the research literature
- Prospective randomized study of sexual function in men taking dutasteride for the treatment of androgenetic alopecia
- Immune Cell-Targeting Biologics for Alopecia Areata: A New Paradigm in Precision Medicine
- 368 The Unanticipated Costs, Deficits, and Other Unexpected Burdens in a Diagnosis of Alopecia Areata
- Central Centrifugal Cicatricial Alopecia Coexisting with Traction Alopecia
- 008 Stratifying alopecia areata systemic treatments: Tailored approaches to disease severity